Summit Therapeutics 주식 (NASDAQ: SMMT)

에 대한 최신 뉴스 Summit Therapeutics (NASDAQ:SMMT) 주식

Summit Therapeutics

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Large Cap

News

Movers

Tech

CIEN

GWRE

IBKR

MRNA

NFLX

ORCL

PLTR

RKLB

SMMT

TWLO

이들 12개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 서밋 테라퓨틱스(NASDAQ:SMMT)의 주식이 30.62% 상승했다. HC 웨인라이트의 애널리스트 미첼 카푸어(Mitchell Kapoor)가 회사에 대해 매수 의견을 재확인하고 44달러의 목표 주가를 유지했다.

넷플릭스, 팔란티어, 모더나 지난주 최고 성과를 보여준 12개 대형주 중 일부 (1월 20일-1월 24일)

Trading Ideas

ALNY

COIN

MBLY

RIVN

STLA

FLSR

이들 11개 대형주들은 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?1. 휴마나(NYSE:HUM)가 별 등급의 2025년 실적 하락과 이것이 2026년 품질 보너스 지급에 어떤 영향을 미칠지에 대해 투자자들에게 업데이트한 후 주가는 24.89% 하락했다. 몇몇 분석가들은 주가 예측을 낮췄다.

코인베이스, 나이키 및 모더나는 지난주 최악의 성과를 보인 11개 대형주 중 일부 (9월 30일-10월 4일)

Exclusives

AAPL

AMZN

APLD

CNEY

GLMD

GOVX

IMRX

INTC

LUMN

LUNR

NDRA

NVDA

SMCI

TNON

TSLA

WHLR

매일 거래일마다 벤징가 프로(Benzinga Pro)에서 수백 개의 헤드라인과 보도자료가 올라온다. 이는 트레이더들이 전체 시장 및 개별 종목에 대한 최신 뉴스를 확인할 수 있는 소스이다. 2024년 9월에 Benzinga Pro에서 가장 많이 검색된 주식들을 살펴보겠다. 현재 가격과 연초 대비 성과는 9월 30일 기준이며 배당금은 포함되지 않았다.

독점: 9월 벤징가 프로에서 가장 많이 검색된 상위 20개 티커 - 테슬라, 엔비디아, 애플은 어디에?

Summit Therapeutics Inc

VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 percent. This is a 81.08 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $121.70 million which beat the analyst consensus estimate of $107.80 million by 12.89 percent. This is a 18.41 percent decrease over sales of $149.15 million the same period last year.

Earnings

Earnings Beats

VAALCO Energy Q4 2024 Adj EPS $0.07 Beats $0.04 Estimate, Sales $121.70M Beat $107.80M Estimate

Reported Earlier, GUESS?, WHP Global Announce Five-Year Deal With Signal Brands To Grow rag & bone Accessories Business

The four compendia comprise Merative Micromedex&#xAE; RED BOOK&#xAE;, First Databank FDB MedKnowledge&#xAE; Drug Pricing, Elsevier Gold Standard Drug Database, and Wolters Kluwer Medi-Span&#xAE; Price Rx&#xAE;.

MESO

Reported Earlier, Mesoblast's Ryoncil Gains Comprehensive Drug Pricing Compendia Access In The U.S.

<ul>
<li>Long-lasting in&nbsp;vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint</li>
<li>No anti-drug antibodies (ADA): no immune rejection of the&nbsp;DMAbs was detected across ~1,000 blood samples, unlike other gene-based antibody delivery approaches where ADA formation has been a challenge</li>
<li>Well-tolerated: most common side effects were mild, temporary injection site reactions such as pain and redness; no serious adverse events (SAEs) related to study drug</li>
<li>Effective target binding: expressed&nbsp;DMAbs successfully bound to the SARS-CoV-2 Spike protein receptor-binding domain (RBD), confirming functional activity through week 72</li>
</ul>

Reported Earlier, INOVIO Announces 72-Week Data From COVID-19 DNA Antibody Trial With No Serious Adverse Events Or Immune Reactions

For February 2025, Copa Holdings' capacity (ASMs) increased by 1.7%, while system-wide passenger traffic (RPMs) increased by 2.3%, compared to 2024. As a result, the system load factor for the month was 86.7%, 0.4 percentage points higher than in February 2024.

Reported Earlier, Copa Holdings Reports February 2025 Load Factor Of 86.7%, Up 0.4% YoY; Traffic Up 2.3%

Inspired Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSE#NASDAQ">INSE</a>) will release its fourth-quarter financial results before the <a href="https://www.benzinga.com/quote/INSE/earnings">opening bell on Monday, March 17.</a>
Analysts expect the New York-based company to report quarterly earnings at 15 cents per share, down from 17 cents per share in the year-ago period. Inspired Entertainment projects quarterly revenue of $79.19 million, compared to $81.2 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 10, Inspired Entertainment announced the expansion of its partnership with Rush Street Interactive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>).
Inspired Entertainment shares fell 6.4% to close at $8.03 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/INSE/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>JMP Securities analyst David Scharf reiterated a Market Outperform rating with a price target of $14 on Jan. 27, 2025. This analyst has an accuracy rate of 66%.</li>
<li>B. Riley Securities analyst David Bain reinstated a Buy rating with a price target of $21 on April 5, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Truist Securities analyst Barry Jonas maintained a Buy rating and cut the price target from $21 to $19 on Oct. 18, 2023. This analyst has an accuracy rate of 65%.</li>
</ul>
Considering buying INSE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="611" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14012828/image-111-1024x611.png" alt="" class="wp-image-824269" style="width:568px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14012828/image-111-1024x611.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14012828/image-111-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14012828/image-111-768x458.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14012828/image-111.png 1110w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298504/top-3-health-care-stocks-youll-regret-missing-this-quarter">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Price Target

Markets

Analyst Ratings

INSE

Inspired Entertainment Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Cellectis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLLS#NASDAQ">CLLS</a>) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 71.93 percent increase over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $33.22 million which beat the analyst consensus estimate of $9.45 million by 251.59 percent. This is a 1.57K percent increase over sales of $1.99 million the same period last year.

CLLS

Cellectis Q4 2024 Adj EPS $(0.16) Beats $(0.17) Estimate, Sales $33.22M Beat $9.45M Estimate

Despite nearly a 50% drop since mid-December,&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are still too expensive to attract seasoned investor Ross Gerber back into the fold.
What Happened: Ross Gerber, the president and CEO of Gerber Kawasaki Wealth &amp; Investment Management, in an <a href="https://www.businessinsider.com/tesla-stock-price-crash-outlook-ross-gerber-elon-musk-tsla-2025-3">interview </a>with Business Insider, stated that he doesn&#8217;t see a clear path for Tesla&#8217;s stock to rebound this year, even after the significant losses.
The long-term Tesla investor maintains that Tesla&#8217;s stock is still overpriced and believes that for the stock to rebound, Tesla&#8217;s earnings need to increase. On Wednesday, Tesla&#8217;s shares were trading at a forward price-to-earnings ratio of 65, more than three times the valuation multiple of the S&amp;P 500. Gerber considers the stock to be overpriced at its current level, particularly as analysts have downgraded the company&#8217;s projected 2025 vehicle sales for the second consecutive year. &#8220;There&#8217;s this game that is happening now where the fundamental story has to be revalued,&#8221; stated Gerber.
The investor also criticized Musk&#8217;s controversial political actions, which he views as a lasting obstacle for the Tesla brand. Musk&#8217;s close association with President Donald Trump has reportedly led to a shift in the brand&#8217;s political alignment, with Tesla reportedly losing liberal support while gaining conservative buyers. 
The spike in people selling their EVs due to Musk&#8217;s political stance has caused a sharp decline in the value of used Tesla cars. In a satirical post on X on Thursday, Ross Gerber also questioned, &#8216;If a liberal sells their tesla to a conservative. How many new Teslas are sold?&#8217; 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="592" height="169" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14003503/image-108.png" alt="" class="wp-image-824241" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14003503/image-108.png 592w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14003503/image-108-300x86.png 300w" sizes="(max-width: 592px) 100vw, 592px" /></figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44312707/sentinelone-stock-slips-as-analysts-cut-price-forecasts-on-soft-guidance-arr-miss-pr?utm_source=taboola&amp;utm_medium=exchange&amp;tblci=GiD1tFFNH-r-bulyXzVS-mm-BVNR3nb6Ojb3DSX9l1ZrFSCN1Vcoub38oPPt0OIfMO-ISg#tblciGiD1tFFNH-r-bulyXzVS-mm-BVNR3nb6Ojb3DSX9l1ZrFSCN1Vcoub38oPPt0OIfMO-ISg">SentinelOne Stock Slips As Analysts Cut Price Forecasts On Soft Guidance, ARR Miss, Product Retirement</a>
Why It Matters: The recent decline in Tesla&#8217;s stock price and its overvaluation, as pointed out by Gerber, are significant in the context of Tesla&#8217;s shifting customer base and the political divide among its customers. Gerber had earlier predicted a 50% drop in Tesla&#8217;s stock this year due to CEO Elon Musk&#8216;s shift in focus to other projects. This prediction has been largely accurate, with Tesla&#8217;s stock falling an additional 31% since his comments in late February.
Gerber also highlighted the challenges Tesla faces in the used car market. He likened it to the &#8220;Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) problem,&#8221; where the product&#8217;s high quality reduces the incentive for customers to upgrade frequently.
Furthermore, a recent analyst note by JPMorgan Chase on Wednesday stated that the company lost too much brand value too quickly. It also warned that the EV maker could see the <a href="https://www.benzinga.com/25/03/44295808/tesla-braces-for-lowest-quarterly-deliveries-since-2022-jpmorgan-predicts-a-brand-has-lost-so-much-value-so-quickly">lowest quarterly </a>deliveries since 2022.
Tesla holds a momentum rating of 89.66% and a growth rating of 55.23%, according to&nbsp;<a href="https://www.benzinga.com/report/TSLA" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s Proprietary Edge Rankings</a>. The Benzinga Growth metric evaluates a stock's historical earnings and revenue expansion across multiple timeframes, prioritizing both long-term trends and recent performance. For an in-depth report on more stocks and insights into growth opportunities,&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">sign</a>&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">up for Benzinga Edge.</a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="452" height="285" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14004726/image-109.png" alt="" class="wp-image-824245" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14004726/image-109.png 452w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14004726/image-109-300x189.png 300w" sizes="(max-width: 452px) 100vw, 452px" /></figure>
Read More:
<ul>
<li> <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44295050/peter-schiff-warns-americans-will-be-harmed-most-when-bitcoin-bubble-pops-says-us-has-biggest-crypto-lobby">Peter Schiff Warns Americans Will Be Harmed Most When Bitcoin Bubble Pops, Says US Has Biggest Crypto Lobby</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Ross Gerber Finds Tesla Stock Expensive Despite Its 50% Plunge: Why The Investor Says EV Giant's 'Fundamental Story Has To Be Revalued'

As the S&amp;P 500 enters into a correction zone, leading economists weigh in on whether the U.S. economy is headed toward a recession amid an escalating trade war.
What Happened: Lawrence H. Summers, former U.S. Treasury Secretary, lambasted recent tariff policies, warning of potential recession risks and negative long-term consequences. In an interview with CNN on Thursday, Summers described these tariff policies as a &#8220;self-inflicted wound&#8221; that not only raises costs for businesses and consumers but also poses a threat to national security. He further stated that these policies are alienating allies while benefiting competitors in Asia and Europe.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Laura Coates Live - Tariffs &amp; Uncertainty: Former Treasury Secretary&#039;s Perspective" width="500" height="281" src="https://www.youtube.com/embed/hqOeYy_dBgo?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Summers also highlighted&nbsp;the economic uncertainty caused by&nbsp;these policies, stating that it&nbsp;discourages spending and investment, which&nbsp;could potentially slow growth. He&nbsp;dismissed the idea of damaging&nbsp;the economy to pressure the&nbsp;Federal Reserve into cutting interest&nbsp;rates as a flawed strategy.
He warned that the odds&nbsp;of a U.S. recession have&nbsp;risen from 10-15% to nearly&nbsp;50%, primarily due to policy shifts. Summers&nbsp;cautioned that arbitrary tariff increases&nbsp;and spending cuts could have&nbsp;long-term negative consequences.
Meanwhile, Mohamed El-Erian, called the speed of the correction &#8216;eye popping&#8217; in his post on X, following the S&amp;P 500&#8217;s 10% drop in three weeks. In his previous posts, he stated that he expects significant downward revisions to the U.S. 2025 growth projections from the IMF and Wall Street firms, ranging from 0.5 to a full percentage point, compared to the initial consensus forecast of 2.5% at the beginning of the year.
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="578" height="217" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13231924/image-106.png" alt="" class="wp-image-824220" style="width:562px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13231924/image-106.png 578w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13231924/image-106-300x113.png 300w" sizes="(max-width: 578px) 100vw, 578px" /></figure>
However, Justin Wolfers, Senior Fellow at Brookings Institute, still holds on to bits of optimism amid pessimism. He told CNN that a recession is &#8216;not inevitable,&#8217; while reasoning that President Donald Trump has inherited a strong U.S. economy and he hasn&#8217;t been at the helm long enough to change much of that.
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="605" height="445" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13233651/image-107.png" alt="" class="wp-image-824228" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13233651/image-107.png 605w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13233651/image-107-300x221.png 300w" sizes="(max-width: 605px) 100vw, 605px" /></figure>
However, he acknowledged that this time, instead of external factors, the chaotic economic policies from the White House are a cause for concern. Wolfers explained how these policies are leading businesses and consumers to pause spending, which &#8216;could&#8217; but &#8216;by no means necessarily&#8217; spark a recession.
SEE ALSO: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44314642/ripple-sec-lawsuit-nears-end-will-xrp-be-classified-as-commodity-like-ethereum">Ripple-SEC Lawsuit Nears End: Will XRP Be Classified As Commodity Like Ethereum?</a>
Why It Matters: The comments from various economists come in the wake of escalating trade tensions. On Thursday, the S&amp;P 500 entered <a href="https://www.benzinga.com/government/regulations/25/03/44317410/sp-500-enters-technical-correction-as-trade-war-fears-rattle-markets">technical correction territory</a>, falling 10% from its all-time high, following Trump&#8217;s latest tariff threats wherein he threatened to impose a 200% tariff on French champagne and EU spirits. 
The S&amp;P 500, as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), closed at 5,521 points, marking a significant drop from its February 19 peak of 6,147. This fresh wave of selling was triggered by escalating trade tensions, reinforcing economists&#8217; concerns about the potential negative impact of recent tariff policies on the economy.
Read More:
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44301836/trump-warns-of-200-tariff-on-french-champagne-and-eu-spirits-in-retaliation-to-europes-tariff-on-us-whiskey">Trump Warns Of 200% Tariff On French Champagne And EU Spirits In Retaliation To Europe&#8217;s Tariff On US Whiskey</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump's Tariff Policies A 'Self-Inflicted Wound' Says Obama-Era Treasury Secretary Larry Summers, Economists Weigh In As S&P Enters Correction Zone

Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) electric vehicle charging stations and home batteries have been excluded from rebates in the Canadian province of British Columbia. This move comes in the wake of tariffs imposed by the U.S. on Canada.
What Happened: BC Hydro, a Crown-owned utility, offers rebates of up to CAD 5,000 ($3464) on eligible battery storage systems and up to CAD 350 ($243) on the purchase and installation of EV chargers. However, Tesla products have been excluded from these rebates since March 12, according to a notice on BC Hydro&#8217;s website, as reported by <a href="https://www.autonews.com/manufacturing/automakers/anc-trump-tariffs-tesla-bc-hydro-rebates-1303/">Auto News</a> on Thursday.
Local media reports indicate that Tesla products such as EV chargers, energy storage batteries, and inverters are a part of the exclusion.
The announcement was made by British Columbia&#8217;s Energy Minister, Adrian Dix, following a review of the program managed by the energy utility BC Hydro. 
"I thought they [Tesla products] shouldn't be made available on a public subsidy program right now. I don't think anyone in British Columbia needs to be told why, and I think most people would support their removal from that list," Dix told CBS
Meanwhile, BC Hydro stated in a release that its rebate program prioritizes Canadian goods while excluding products made in the U.S. &#8220;where practicable.&#8221;
Customers who received pre-approval for Tesla products before March 12 will still be eligible for their rebates. 
See Also: <a href="https://www.benzinga.com/markets/25/03/44276820/elon-musk-reportedly-pledges-100-million-to-trump-linked-political-groups-amid-billion-dollar-losses-in-his-net-worth">Elon Musk&#8217;s Tesla Set For Lowest Quarterly Deliveries Since 2022, JPMorgan Predicts: &#8216;Brand Has Lost So Much Value So Quickly&#8217;</a>
Why It Matters: The decision comes after U.S. President Donald Trump imposed a 25% tariff on Canadian goods and a 10% tariff on Canadian energy on March 4. The surtax was temporarily suspended on March 6 for goods that comply with the United States-Mexico-Canada Agreement but is anticipated to be reinstated on April 2.
Tesla is encountering consumer backlash in the U.S. over CEO Elon Musk&#8216;s close ties to President Trump. Musk had also described Canada as "not a real country"&nbsp;in a post on X which he later deleted. There was also a widespread call for revoking the Tesla CEO&#8217;s Canadian citizenship.
Not just, British Columbia, but, the province of Ontario had previously terminated a C$100 million ($69.28 million) contract with Musk's Starlink, while the city of Toronto left Tesla out of its driver incentive program.
This development comes on the heels of allegations against Tesla for manipulating the EV rebate program in Canada. <a href="https://www.benzinga.com/25/03/44213295/tesla-suspected-of-ev-rebate-manipulation-in-canada-amid-sudden-sales-surge-tesla-gamed-the-system-says-industry-body">Four Canadian Tesla stores</a> were suspected of exploiting the country's EV rebate program by selling an average of 30 cars per hour over three days, claiming over 50% of the rebate funds.
Tesla holds a momentum rating of 83.63% and a growth rating of 55.20%, according to&nbsp;<a href="https://www.benzinga.com/report/TSLA" target="_blank" rel="noreferrer noopener">Benzinga's Proprietary Edge Rankings</a>. The Benzinga Growth metric evaluates a stock&#8217;s historical earnings and revenue expansion across multiple timeframes, prioritizing both long-term trends and recent performance. For an in-depth report on more stocks and insights into growth opportunities,&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">sign</a>&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">up for Benzinga Edge.</a>
Tesla stock declined 2.99% to close at $240.68 on Thursday. The stock has lost over 36% year-to-date. 
Read More
<ul>
<li><a href="https://www.benzinga.com/25/03/44317253/pricing-trends-for-consumer-goods-continue-to-normalize-easing-pressure-on-consumers-says-analyst"> JP Morgan Analyst Sees Inflation Easing, But Tougher Price Comparisons Loom For Key Categories</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tesla Charging Stations Cut From Rebate Program By Canadian Province: 'Most People Would Support Their Removal' From Subsidy List, Says Minister

Major U.S. indices experienced turbulent sessions on Thursday, with the S&amp;P 500 <a href="https://in.benzinga.com/government/regulations/25/03/44317410/sp-500-enters-technical-correction-as-trade-war-fears-rattle-markets">entering technical correction territory</a>. The index fell 10% from its all-time high, rattled by escalating trade tensions and the latest tariff threats from President Donald Trump. Despite recent inflation data painting a more optimistic picture for the U.S. economy, investors remain focused on trade policy risks, worrying that escalating tariffs could undermine corporate earnings and disrupt supply chains.
The S&amp;P 500 index fell by nearly 1.4%, closing at 5,521.52, while the Nasdaq dropped almost 2%, finishing at 17,303.02. The Dow Jones Industrial Average also ended Thursday down 1.3%, at 40,813.57.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
D-Wave Quantum Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>)
D-Wave Quantum shares surged 18.73%, closing at $6.91 after hitting an intraday high of $7.12 and a low of $6.04. The stock&#8217;s 52-week high and low are $11.41 and $0.75, respectively. On Thursday, the company reported a fourth-quarter adjusted earnings loss of 8 cents per share, missing the street view by a cent. Despite a 21% year-over-year decline in quarterly sales to $2.309 million, <a href="https://www.benzinga.com/25/03/44301722/d-wave-quantum-stock-rallies-on-strong-q4-booking-growth-and-optimistic-outlook">strong booking growth</a> and an optimistic outlook fueled investor interest.
DocuSign Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>)
DocuSign&#8217;s stock fell 6.78% to close at $74.70, with an intraday high of $79.36 and a low of $74.26. The company&#8217;s 52-week range is $107.86 to $48.70. The company&#8217;s stock shot up 11.65% to $83.40 in the after-hours trading. DocuSign reported fourth-quarter revenue of $776.3 million, surpassing the consensus estimate. The <a href="https://www.benzinga.com/news/earnings/25/03/44317205/docusign-q4-earnings-revenue-beat-eps-beat-billings-up-11-shares-move-higher-despite-soft-guidance">earnings per share</a> also beat expectations.
Ulta Beauty Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>)
Ulta Beauty&#8217;s shares declined by 4.48%, ending the day at $314.47. However, in the after-hours trading the stock shot up by 6.5% to $335. The shares reached an intraday high of $329.54 and a low of $309.01, with a 52-week high of $574.76 and a low of $309.01. The company reported <a href="https://www.benzinga.com/news/earnings/25/03/44317611/ulta-beauty-stock-climbs-on-q4-earnings-beat-fiscal-2025-will-be-a-pivotal-year">fourth-quarter revenue</a> of $3.49 billion, exceeding estimates. Earnings per share were also above expectations, marking fiscal 2025 as a pivotal year.
Meta Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
Meta Platforms saw a 4.67% decline, closing at $590.64. The stock&#8217;s intraday high was $620.50 with a low of $586.51, and a 52-week range of $740.91 to $414.50. The decline came amid a broader market sell-off, with <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44317112/meta-shares-drop-during-market-sell-off-and-tariff-concerns-whats-going-on">tariff concerns</a> affecting tech stocks.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla&#8217;s stock decreased by 2.99%, closing at $240.68. The intraday high was $248.29, and the low was $232.60, with a 52-week high of $488.54 and a low of $138.80. Analysts at JPMorgan predict Tesla will have its <a href="https://www.benzinga.com/25/03/44295808/tesla-braces-for-lowest-quarterly-deliveries-since-2022-jpmorgan-predicts-a-brand-has-lost-so-much-value-so-quickly">lowest quarterly deliveries</a> since 2022, citing CEO Elon Musk&#8217;s involvement in the Trump administration as a factor impacting the brand&#8217;s value.
Image via Shutterstock
Prepare for the day&#8217;s trading <a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a> by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44320890/cathie-wood-hunts-for-crypto-bargains-amid-bitcoin-decline-ark-loads-up-on-robinhood-and-coinbase">Cathie Wood Hunts For Crypto Bargains Amid Bitcoin Decline, Ark Loads Up On Robinhood And Coinbase</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Equities

DOCU

QBTS

ULTA

D-Wave Quantum, Docusign, Ulta Beauty, Meta Platforms, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Gogo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) will release its fourth-quarter financial results, before the opening bell, on <a href="https://www.benzinga.com/quote/GOGO/earnings">Friday, March 14</a>.
Analysts expect the Broomfield, Colorado-based company to report quarterly earnings at 9 cents per share, down from 11 cents per share in the year-ago period. Gogo projects quarterly revenue of $97.8 million, compared to $97.81 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 4, 2024, Gogo announced the completion of its acquisition of Satcom Direct. The company also named Chris Moore, President of SD, as Gogo&#8217;s Chief Executive Officer.
Gogo shares fell 1.2% to close at $6.87 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/gogo/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Roth MKM analyst Scott Searle maintained a Buy rating with a price target of $15.5 on Sept. 17, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Morgan Stanley analyst Simon Flannery maintained an Equal-Weight rating and cut the price target from $12 to $11 on Sept. 3, 2024. This analyst has an accuracy rate of 66%.</li>
<li>JP Morgan analyst Philip Cusick maintained a Neutral rating and cut the price target from $11 to $10 on Aug. 8, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying GOGO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="539" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13223755/image-105-1024x539.png" alt="" class="wp-image-824202" style="width:497px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13223755/image-105-1024x539.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13223755/image-105-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13223755/image-105-768x404.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13223755/image-105.png 1181w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298504/top-3-health-care-stocks-youll-regret-missing-this-quarter">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Pre-Market Outlook

GOGO

Top Wall Street Forecasters Revamp Gogo Price Expectations Ahead Of Q4 Earnings

On Thursday, Cathie Wood&#8216;s Ark Invest made significant trades, focusing on acquiring shares in Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), and Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>). These transactions come amid a volatile market environment, particularly affecting cryptocurrency-related stocks.
The Robinhood Trade saw Ark Invest&#8217;s ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) fund purchasing 143,855 shares of Robinhood. The stock closed at $36.02, resulting in a total investment of approximately $5.18 million. This move aligns with recent market trends, where Robinhood, alongside other crypto-related stocks, <a href="https://www.benzinga.com/25/03/44225814/bitcoins-drop-shakes-crypto-stocks-coin-hood-mara-riot-dip-but-are-traders-seeing-a-bargain">faced pressure</a> due to Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) decline below $80,000. Despite these challenges, traders are reportedly looking for potential opportunities in the market.
The Coinbase Trade involved Ark Invest&#8217;s ARKK fund acquiring 29,353 shares of Coinbase. With a closing price of $177.49, the investment totaled around $5.21 million. Coinbase has been under scrutiny following its exclusion from the S&amp;P 500 and the broader cryptocurrency market&#8217;s downturn. However, analysts like Chris Brendler from Rosenblatt have <a href="https://in.benzinga.com/25/03/44194807/coinbase-analyst-sees-crypto-spring-ahead-calls-recent-pullback-a-buying-opportunity">maintained a positive outlook</a>, suggesting the recent pullback presents a buying opportunity.
The Tempus AI Trade featured Ark Invest&#8217;s ARKK fund buying 30,119 shares of Tempus AI Inc. The shares closed at $42.16, amounting to an investment of approximately $1.23 million. This purchase follows Ark&#8217;s <a href="https://www.benzinga.com/25/03/44293571/cathie-woods-wednesday-moves-ark-pours-1-36-million-into-tempus-ai-shares-following-deep-6-ai-acquisition-offloads-rocket-lab-stock">previous $1.36 million</a> investment in Tempus AI on Wednesday. Notably, Ark has purchased Tempus AI stock on every day of this week. Amid the Tech stock bloodbath on Monday, it had scooped up a whopping $13.23 million worth of shares.
Other Key Trades:
<ul>
<li>ARKW purchased 109,818 shares of Ibotta Inc (IBTA) while ARKF fund bought 16,332 shares.</li>
<li>ARKG fund purchased 17,742 shares of CRISPR Therapeutics AG (CRSP), while ARKK scooped up 88,232 shares.</li>
<li>ARKK fund sold 967,513 shares of UiPath Inc (PATH) and ARKW sold 133,703 shares.</li>
</ul>
Image via Shutterstock
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44320586/bitcoin-sees-potential-bullish-breakout-toward-91000">Bitcoin&#8217;s Two-Year Bull Run At Risk? Analyst Says Chart Hints At &#8216;Potential Trend Shift&#8217; — Asks Followers To Watch This Level Closely</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

ETFs

General

$BTC

ARKK

HOOD

Cathie Wood Hunts For Crypto Bargains Amid Bitcoin Decline, Ark Loads Up On Robinhood And Coinbase

Spirit Aviation Holdings, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SAVEQ#OTC">SAVEQ</a>), the parent company of Spirit Airlines, LLC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SAVEQ#OTC">SAVEQ</a>) announced that it has successfully completed its financial restructuring.
What Happened: The&nbsp;United States Bankruptcy Court for&nbsp;the Southern District of New&nbsp;York has confirmed Spirit&#8217;s Plan of Reorganization, with a supermajority of the company&#8217;s loyalty and convertible noteholders offering immense support, stated the company via press release. The restructuring process allowed the company to reduce its funded debt by nearly $795 million, leaving Spirit in a robust financial position. The company also secured&nbsp;a $350 million equity investment&nbsp;from current investors, aimed at supporting future initiatives and enhancing guest experiences. 
Upon emergence, the common stock previously issued by Spirit Airlines, Inc. was canceled. The company said that it &#8220;expects to re-list its shares on a stock exchange as soon as reasonably practicable&#8221; after the Effective Date of its Plan of Reorganization.
President and CEO Ted Christie stated, &#8220;Today, we&#8217;re moving forward with our strategy to redefine low-fare travel with our new, high-value travel options.&#8221;
See Also:<a href="https://www.benzinga.com/news/25/03/44308149/market-is-trying-to-rebound-keep-trump-off-x-says-jim-cramer-also-calls-out-canadas-carney-for-making-trump-look-bad-really-bad-call"> &#8216;Market Is Trying To Rebound—Keep Trump Off X,&#8217; Says Jim Cramer—Also Calls Out Canada&#8217;s Carney For Making Trump Look Bad—&#8217;Really Bad Call&#8217;</a>
Why It Matters: This development comes after Spirit Airlines <a href="https://benzinga.com/25/02/43654635/spirit-airlines-rejects-frontiers-new-merger-offer-aims-to-finalize-restructuring-by-q1-2025">rejected a merger</a> offer from&nbsp;Frontier Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>)&nbsp;earlier in February 2025. Frontier had proposed a revised restructuring plan, offering Spirit&#8217;s stakeholders $400 million in second-lien debt and 19% of Frontier&#8217;s common equity. This would have eliminated the need for Spirit&#8217;s $350 million equity rights offering but required a waiver of a $35 million termination fee. 
The rejection of this offer indicated Spirit&#8217;s confidence in its own restructuring plan, which it has now successfully implemented. The company&#8217;s decision to deleverage debt and secure equity investment underscores its commitment to financial stability and enhanced passenger services. The successful restructuring also paves the way for Spirit&#8217;s potential re-listing on a stock exchange, marking a significant turnaround for the airline. 
Price Action: Spirit Airlines OTC stock ended Thursday 2.6% higher at $0.47, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">data from Benzinga Pro</a>.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/politics/25/03/44319499/elon-musk-disapproval-rating-53-in-new-poll-62-say-tesla-ceo-doesnt-have-right-experience-to-make-changes-to-government">Elon Musk Disapproval Rating 53% In New Poll: 62% Say Tesla CEO Doesn&#8217;t Have &#8216;Right Experience&#8217; To Make Changes To Government</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

SAVEQ

ULCC

Spirit Airlines Soars Out of Bankruptcy, Says Will Cancel Old Stock And Expects To Re-List 'As Soon As Reasonably Practicable'

Donald Tang, the Executive Chair of Chinese fast-fashion retailer Shein, assured that the company is preparing for a London listing while dismissing concerns about the company&#8217;s valuation.
What Happened: Shein initially planned a New York listing for late 2023 but redirected its focus to the U.K. after the U.S. Securities and Exchange Commission (SEC) rejected its proposal. The fast-fashion retailer has decided to go ahead with the listing despite U.S. President Donald Trump's decision to eliminate the &#8220;de minimis&#8221; duty-free exemption for Chinese imports valued under $800. Tang stated that the company "has always had a globalized model, so we've already started to do global diversification", as reported by the <a href="https://www.ft.com/content/b0f841c8-2944-4ea6-88dc-651e46cda336">Financial Times</a>.
Shein&#8217;s valuation stood at $66 billion during its latest funding round in 2023. However, some stakeholders have been pushing for a reduction in the valuation to around $30 billion, a move that could expedite its&nbsp;IPO in the first half&nbsp;of this year.
Tang revealed that none of the existing investors, including Sequoia China (now HongShan), General Atlantic,&nbsp;and Abu Dhabi sovereign wealth&nbsp;fund Mubadala, have expressed concerns about Shein&#8217;s valuation in the lead-up to its planned IPO.
Although the company&#8217;s valuation is considerably lower, its flotation would still be among the largest on the London market this decade, as per the FT. 
Tang&nbsp;confirmed that there have been &#8220;zero conversations&#8221; about reducing its valuation among Shein&#8217;s management. &#8220;When&nbsp;we are actually going public,&nbsp;there will be that question&nbsp;[about valuation], but we&#8217;re&nbsp;not going public right now,&#8221; he stated.
See Also: <a href="https://www.benzinga.com/25/03/44320221/chuck-schumer-says-a-government-shutdown-will-give-trump-the-keys-to-the-city-state-and-country-and-elon-musk-the-chance-to-destroy-government-services">Chuck Schumer Says A Government Shutdown Will Give Trump The &#8216;Keys To The City, State and Country&#8217; And Elon Musk The Chance To Destroy Government Services</a>
Why It Matters: Tang&#8217;s comments come in as Shein faces stiff&nbsp;competition from rival group Temu&nbsp;and uncertainty over the future&nbsp;of a key exemption to&nbsp;U.S. import duties. Additionally, sources informed the FT that the company&#8217;s net profit declined by 40% to $1 billion in 2024. However, Tang asserts that investors are &#8220;very happy&#8221; as the company continues to expand successfully and profitably on a large scale while enhancing efficiency and minimizing waste.
Furthermore, Shein, along with Amazon and Temu, is under <a href="https://www.benzinga.com/25/02/43431559/amazon-temu-and-shein-under-eu-scrutiny-regulators-target-illegal-products-and-tougher-e-commerce-rules">regulatory scrutiny</a> from the EU for allegedly selling dangerous or illegal products online. This could potentially impact the company&#8217;s performance and reputation, making its upcoming listing a significant event to watch.
Photo Courtesy: Yau Ming Low On Shutterstock.com
Read More: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44317410/sp-500-enters-technical-correction-as-trade-war-fears-rattle-markets">S&amp;P 500 Enters Technical Correction As Trade War Fears Rattle Markets</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Shein CEO Says 'Zero Conversations' About Slashing $66B Valuation Ahead Of IPO, Backers Unfazed Amid Trump Tariff Woes

On Thursday, prominent cryptocurrency analyst Ali Martinez shared insights on Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) potential price movements. 
What Happened: The analyst urged his followers to monitor the $74,000 level closely. Sharing a weekly Bitcoin-Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) chart, he noted that losing this key support could indicate a &#8220;potential trend shift.&#8221; He noted that such a shift would be the first one since January 2023.
A sell signal occurred during the bearish trend in 2022, while a buy signal marked the start of a strong uptrend in early 2023, according to the shared chart.
Between January 2023 and now, Bitcoin has surged from $16,625.08 to over $80,000, marking a nearly 390% gain during this period.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Watch $74,000 closely! The weekly chart hints at a potential trend shift if <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> loses this key support. The first major one since January 2023! <a href="https://t.co/taNh5dLSQT">pic.twitter.com/taNh5dLSQT</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1900342613431247359?ref_src=twsrc%5Etfw">March 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Martinez noted, in a separate post, that long-term holders have been accumulating Bitcoin. He said that these holders have added 131,000 BTC to their wallets in the past month.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Long-term <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> holders have been on a buying spree, adding over 131,000 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> to their wallets in the past month! <a href="https://t.co/7CWlWXX2uh">pic.twitter.com/7CWlWXX2uh</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1900324997287338062?ref_src=twsrc%5Etfw">March 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
On the other hand, Ali, noted that 36,000 BTC have been withdrawn from exchanges in the 96 hours. This move is seen as a positive sign for the market, as it indicates confidence among investors who are holding onto their assets despite price volatility.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Over 36,000 <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> have been withdrawn from exchanges in the last 96 hours! <a href="https://t.co/BVOhL0I6uO">pic.twitter.com/BVOhL0I6uO</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1900268877705097684?ref_src=twsrc%5Etfw">March 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/global/25/03/44296984/libra-token-fallout-argentine-lawyer-demands-extradition-of-project-creator-from-us">Libra Token Fallout: Argentine Lawyer Demands Extradition Of Project Creator From US</a>
Why It Matters: The current landscape for Bitcoin is marked by significant developments and varied perspectives. Recently, President Donald Trump announced a <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44184474/trump-announced-strategic-bitcoin-reserve-to-allow-buying-additional-btc-peter-schiff-doesnt-think-so-but-heres-what-the-order-says">Strategic Bitcoin Reserve</a>, which, while initially seen as bullish, ultimately disappointed investors due to its reliance on seized assets rather than new purchases.This move reflects a shift in government attitudes toward digital assets, though its impact on Bitcoin&#8217;s price has been mixed. Additionally, regulatory clarity has been a focus, with the SEC providing relief by closing non-fraud investigations and clarifying its <a href="https://in.benzinga.com/25/02/44032560/memecoins-like-trump-dogecoin-pepe-not-securities-says-the-sec-but-fraud-related-to-offer-and-sale-subject-to-enforcement">stance on memecoins</a>. 
Meanwhile, Bitcoin&#8217;s price has <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44212362/bitcoin-ethereum-and-dogecoin-crash-as-trump-refuses-to-rule-out-recession-arthur-hayes-predicts-btc-to-retest-78000">experienced volatility</a>, dropping from an all-time high in January 2025 to recent lows below the psychologically important $80,000 level, influenced by macroeconomic factors and market sentiment. 
Price Action: At the time of writing, Bitcoin was down 2.6%, trading at $81,351, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">data from Benzinga Pro</a>.
Image via Shutterstock
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44298759/bitcoin-vs-lunr-intuitive-machines-stock-might-see-larger-price-swings-than-btc-in-days-ahead">Bitcoin Vs. LUNR: Intuitive Machines Stock Might See Larger Price Swings Than BTC In Days Ahead</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDT

Bitcoin's Two-Year Bull Run At Risk? Analyst Says Chart Hints At 'Potential Trend Shift' — Asks Followers To Watch This Level Closely

Sen. Chuck Schumer (N.Y.), the Senate Democratic Leader, expressed concerns about a potential government shutdown on Thursday. He warned that such an event could empower Donald Trump significantly. 
What Happened: Schumer&#8217;s remarks come amid heightened tensions in Congress over federal funding, with Democrats and Republicans blaming each other for the impasse. Schumer specifically mentioned Elon Musk, suggesting that the entrepreneur supports a shutdown and is planning to leverage it to dismantle essential government programs.
Schumer&#8217;s post on X highlighted the stakes involved, stating, &#8220;A shutdown would give Donald Trump the keys to the city, state, and country.&#8221; He accused Musk of wanting a shutdown to &#8220;expedite the destruction of key government programs and services.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A shutdown would give Donald Trump the keys to the city, state, and country. Musk has said he wants a shutdown, and reporting has shown he is already making plans to use the shutdown to expedite his destruction of key government programs and services.
&mdash; Chuck Schumer (@SenSchumer) <a href="https://twitter.com/SenSchumer/status/1900339650562011205?ref_src=twsrc%5Etfw">March 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The tweet was part of the ongoing debate in Congress, where Schumer and other leaders are pushing for a &#8220;clean 30-day CR&#8221; to avoid a shutdown. This situation has escalated as the deadline looms, with both parties intensifying their rhetoric.
Schumer announced he will support advancing a House-passed six-month government funding bill, despite opposition from many Democrats who call it a "slush fund" for Trump and Musk. He argued that while the bill is flawed, failing to pass it could lead to a government shutdown with severe consequences for veterans, seniors, and disabled individuals, <a href="https://thehill.com/homenews/senate/5194156-schumer-gop-funding-bill-shutdown/">reported</a> The Hill.
Schumer is the second Senate Democrat to back advancing the GOP bill, likely giving cover to others still reviewing it. Senate Republicans, holding 53 seats, need eight Democratic votes to advance the GOP-drafted resolution, which boosts defense spending by $6 billion while cutting non-defense programs by $13 billion. Sen. Rand Paul (R-Ky.) opposes it, citing insufficient deficit reduction.
See Also: <a href="https://www.benzinga.com/25/03/44239145/elizabeth-warren-raises-questions-on-robert-f-kennedys-mar-a-lago-dinners-with-big-pharma-american-people-deserve-to-know-about-the-deals-made">Elizabeth Warren Raises Questions On Robert F Kennedy&#8217;s Mar-A-Lago Dinners With Big Pharma: American People Deserve To Know About The Deals Made</a>
Why It Matters: The potential government shutdown has significant implications for the nation. Schumer&#8217;s warning about Trump&#8217;s influence highlights the broader political stakes. As reported, Schumer has blamed the GOP for taking a <a href="https://www.benzinga.com/news/25/03/44294067/chuck-schumer-blames-gop-for-partisan-path-as-shutdown-nears-republicans-say-democrats-fault-if-government-closes">&#8220;partisan path&#8221;</a> in the funding debate, while Republicans argue that Democrats would be at fault if a shutdown occurs. The standoff reflects deep divisions in Congress, with both parties holding firm on their positions.
Alexandria Ocasio-Cortez has also criticized Republicans, emphasizing the <a href="https://www.benzinga.com/25/03/44293219/aoc-claps-back-at-mike-johnson-as-senate-moves-closer-to-government-shutdown-if-you-need-democrats-then-you-need-to-negotiate">need for negotiation</a> if they lack the votes to pass their funding bill. She said, &#8220;If you need Democrats, then you need to negotiate with Democrats.&#8221;
Photo via Shutterstock
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Government

Politics

Chuck Schumer Says A Government Shutdown Will Give Trump The 'Keys To The City, State and Country' And Elon Musk The Chance To Destroy Government Services

&#8220;When do you keep a stock? When do you sell it, and when do you add to it?&#8221; That's the question <a href="https://www.benzinga.com/personal-finance/25/02/43737751/suze-orman-weighs-in-on-trumps-tariffs-says-the-real-problem-is-28000-florida-home-insurance-what-are-you-going-to-do-about-that">Suze Orman</a> recently posed on her "Women &amp; Money" podcast — and it's one that many investors struggle with, especially during market volatility. Investing in the stock market can be intimidating, and when prices start to drop, it's easy to panic and make emotional decisions. But Orman advises that reacting out of fear is often a mistake.&nbsp;
<h2 class="wp-block-heading">Why Fear Can Be Dangerous for Investors</h2>
&#8220;The main internal obstacle to wealth is fear,&#8221; Orman said. &#8220;Fear, everybody, just that simple.&#8221; She pointed out that fear is pervasive right now, driven by economic uncertainty, rising costs, and geopolitical tensions.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
</ul>
This fear can lead to knee-jerk reactions in the stock market. Orman explained that when investors panic and sell off stock, it can drive prices down further. Orman used Palantir as an example. In the last month, it has dropped from about $125 a share to below $80 a share.&nbsp;&nbsp;
&#8220;You feel good for a while, cause maybe you sold <a href="https://www.benzinga.com/markets/equities/25/03/44212796/palantir-joins-sp-100-after-ai-driven-rally-stock-surges-almost-60-since-trump-victory">Palantir</a> at 95, and now here it&#8217;s at 85 and you feel like such a winner. Are you kidding me?&#8221; she said, adding that short-term gains from selling out of fear can result in missed long-term growth opportunities.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
<h2 class="wp-block-heading">When to Keep a Stock</h2>
Orman advises that if a stock has strong fundamentals — good management, a solid product, and future growth potential — you should hold onto it even if the market dips. She reminded listeners about the market downturn in 2022 when major tech stocks like Apple, Microsoft, and Nvidia performed poorly. &#8220;They were referred to as the Stinky 7 because of how badly they had gone down,&#8221; Orman said.
But those who stayed invested saw significant returns. Nvidia, for example, rebounded with a 240% gain in 2023. Orman reminded listeners that those who bought stock at much lower prices were still sitting on significant gains. And even if they didn't, if the stock is fundamentally strong, it&#8217;s better to stay invested rather than react impulsively to market swings.
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
<h2 class="wp-block-heading">When to Sell a Stock</h2>
While holding onto <a href="https://www.benzinga.com/money/best-stocks-for-long-term-investment">strong stocks</a> can lead to long-term gains, there are times when selling makes sense. Orman advised selling if a stock's value becomes too large a portion of your overall portfolio. This helps to reduce the risk of losing too much if the stock suddenly drops.
She explained that selling can also be a smart move if you need the funds for other investments or financial goals. However, Orman warned against selling just because the stock has gone up or down temporarily. Taking profits too soon can lead to missed opportunities if the stock rebounds.
<h2 class="wp-block-heading">When to Add to a Stock</h2>
Orman supports adding to a stock position when you have the funds to do so strategically — through <a href="https://www.benzinga.com/personal-finance/25/02/43759719/suze-school-lump-sum-investing-dollar-cost-averaging-and-value-cost-average-which-is-her-favorite">dollar-cost averaging</a>. This means investing smaller amounts consistently over time, which reduces the risk of buying at a peak. &#8220;You have another $300 that you can put into Palantir totally. So all right, put $50 at a time in it so that you have at least six more times that you can buy the stock if it continues to go down,&#8221; she advised.
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Orman shared her own strategy with Palantir. She mentioned how she bought more shares when the price dropped from $113 to $98 and again when it hit $85. She said this approach lowers the average cost per share over time and allows for greater potential gains when the stock eventually rises. However, she also cautioned that this strategy works best for those who have the funds to continue buying as the price drops.
<h2 class="wp-block-heading">Bottom Line</h2>
Orman's advice boils down to staying calm and focused on long-term growth rather than reacting to market fear. Keeping, selling, or adding to a stock should be based on the strength of the company and your overall financial strategy — not panic over market swings.
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>

Personal Finance

'When Do You Keep A Stock? When Do You Sell It, And When Do You Add To It?' Suze Orman Says Don't Sell Out Of Fear

NAOV

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

APDN

Press Releases

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics to Present at Upcoming Investor Conferences

Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025

Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

AbbVie

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals

Amgen

argenx

Ascendis Pharma A/S - American Depositary Shares

Ascendis Pharma

Biogen

BioMarin Pharmaceutical Inc. - Common Stock

Biomarin Pharmaceutical

BioNTech

Exact Sciences Corporation - Common Stock

Exact Sciences

Exelixis

Gilead Sciences

Genmab

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Incyte

Insmed

Moderna

Neurocrine Biosciences, Inc. - Common Stock

Neurocrine Biosciences

Natera

BeiGene, Ltd. - American Depositary Shares

BeiGene

Vaxcyte

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals

Roivant Sciences

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

United Therapeutics Corporation - Common Stock

United Therapeutics

Vertex Pharmaceuticals Incorporated - Common Stock

Vertex Pharmaceuticals

Evercore ISI Group

Goldman Sachs

Citizens Capital Markets

HC Wainwright & Co.

Truist Securities

이들 12개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주식이 30.62% 상승했다. HC 웨인라이트의 애널리스트 미첼 카푸어(Mitchell Kapoor)가 회사에 대해 매수 의견을 재확인하고<a href="https://www.benzinga.com/quote/smmt/analyst-ratings" target="_blank" rel="noreferrer noopener"> 44달러의 목표 주가를 유지</a>했다.
2. 로켓랩 USA(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/43170776" target="_blank" rel="noreferrer noopener">파이어플라이 에어로스페이스의 블루 고스트 밀리언(Blue Ghost Million) 1</a>에 대한 발사 지원을 발표한 후 23.21% 급등했다.
3. 모더나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)의 주식이 회사가 유럽연합, <a href="https://www.benzinga.com//node/43196950" target="_blank" rel="noreferrer noopener">노르웨이 및 북마케도니아</a>에 mRNA COVID-19 백신 공급 입찰에서 선정되었다고 발표한 후 22.66% 상승했다.
4. 트윌리오(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>)의 주식은 회사가 4분기 실적 가이던스를 예상보다 상향 조정하고 전년 대비 매출 증가를 발표한 후  18.84% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com//node/43194564" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
5. 인터랙티브 브로커스 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/43132552" target="_blank" rel="noreferrer noopener">4분기 실적이 예상보다 좋게</a> 나타난 후 16.38% 상승했다.
6. 넷플릭스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>)의 주식이 16.05% 상승했다. 회사가 <a href="https://www.benzinga.com//node/43114866" target="_blank" rel="noreferrer noopener">4분기 재무 실적이 예상보다 좋게 나타난</a> 후 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/NFLX/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
7. 오라클(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/43122667" target="_blank" rel="noreferrer noopener">생성 AI</a>와 지능형 에이전트를 도입하여 오라클 퓨전(Oracle Fusion) 클라우드 판매 및 고객 프로세스를 혁신했다고 발표한 후 15.08% 상승했다.
8. 시에나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>)의 주식이 14.97% 상승했다.
9. JD닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)의 주식이 14.96% 상승했다. 트럼프가 중국의 관세 위협을 무시한 후, 중국 주식도 보험사들이 주식에 투자하도록 유도하고 시장을 지원하려는 노력으로 상승했다.
10. 가이드와이어 소프트웨어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>)의 주식이 14.57% 상승했다. 골드만삭스가 주식을 매수 등급으로 커버리지를 시작하고 210달러의 목표 주가를 발표한 후이다. 또한 회사는 <a href="https://www.benzinga.com//node/43148643" target="_blank" rel="noreferrer noopener">S&amp;P MidCap 400에 편입될 예정</a>이다.
11. 위프로(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/WIT#NYSE">WIT</a>)의 주식이 14.24% 상승했다. 회사가 <a href="https://www.benzinga.com//node/43054648" target="_blank" rel="noreferrer noopener">3분기 재무 실적이 예상보다 좋았다고 발표하고</a> 중간 배당금을 발표한 후다.
12. 팔란티어 테크놀로지스(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)의 주식이 14.07% 상승했다. 아마도 트럼프 대통령이 <a href="https://www.benzinga.com//node/43157322" target="_blank" rel="noreferrer noopener">로젝트 스타게이트</a>, 5,000억 달러 규모의 AI 인프라 투자 계획을 발표한 후이다.
이미지 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 11개 대형주들은 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 휴마나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>)가 별 등급의 2025년 실적 하락과 이것이 <a href="https://www.benzinga.com//node/41140319" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">2026년 품질 보너스 지급에 어떤 영향</a>을 미칠지에 대해 투자자들에게 업데이트한 후 주가는 24.89% 하락했다. 몇몇 분석가들은 <a href="https://www.benzinga.com/quote/hum/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 예측</a>을 낮췄다.
2. 스텔란티스 N.V.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>)의 주가는 크라이슬러 모기업의 미국 판매가 <a href="https://www.benzinga.com//node/41147560" target="_blank" rel="noreferrer noopener">3분기에 20% 급락</a>했다고 발표한 후 17.06% 하락했다. <a href="https://www.benzinga.com//node/41190669" target="_blank" rel="noreferrer noopener">여러</a> 애널리스트들이 <a href="https://www.benzinga.com/quote/stla/analyst-ratings" target="_blank" rel="noreferrer noopener">주식을 하향 조정</a>했다.
3. 코인베이스 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)의 주식은 10.63% 하락했다. 이 회사는 <a href="https://www.benzinga.com//node/41171878" target="_blank" rel="noreferrer noopener">MICA 유럽 규정을 충족하지 않는</a> 스테이블코인에 대한 서비스를 제한할 것이라고 발표했다.
4. 모빌아이 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>)의 주식은 10.15% 하락했다.
5. 리비안 오토모티브(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>)는 <a href="https://www.benzinga.com//node/41182921" target="_blank" rel="noreferrer noopener">R1 및 RCV 플랫폼의 공유 부품</a> 공급 부족으로 인해 회사가 연간 생산 지침을 낮춘 후 지난 주 주가는 10% 하락했다.
6. 퍼스트 솔라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLSR#NASDAQ">FLSR</a>)의 주식은 9.63% 하락했다.
7. 콘아그라 브랜즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>)의 주식은 <a href="https://www.benzinga.com//node/41140181" target="_blank" rel="noreferrer noopener">1분기 재무 실적이 예상보다 저조</a>하게 나타났다고 보고한 후 9.12% 하락했다.
8. 플로어 &amp; 데코 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FND#NYSE">FND</a>)의 주식은 8.81% 하락했다.
9. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주가는 8.59% 급락했다. 이 회사는 <a href="https://www.benzinga.com//node/41174110" target="_blank" rel="noreferrer noopener">2차 EGFRm 비소세포폐암(NSCLC) 대상 HARMONi 임상 3상 시험의 등록 완료</a>되었다고 발표했다.
10. 모더나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)의 주가는 8.44% 하락했다. 이 회사는 앨라일람 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>)와 진행 중인 특허 침해 소송에서 <a href="https://www.benzinga.com//node/41169029" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">합의에 도달</a>했다.
11. 나이키(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) 주식은 여러 투자 은행들이 <a href="https://www.benzinga.com//node/41147332" target="_blank" rel="noreferrer noopener">1분기 매출 부진에 따라 목표 주가를 하향 조정</a>한 후 8.04% 하락했다.
또한 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%A4%91%EA%B5%AD-%EC%A3%BC%EC%8B%9D%EC%9D%B4-%EC%A3%BC%EB%8F%84-%EB%A6%AC-%EC%98%A4%ED%86%A0%EC%99%80-jd%EB%8B%B7%EC%BB%B4%EC%9D%80-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1/" target="_blank" rel="noopener">미국에 상장된 중국 주식이 또 한 주를 장악 &#8211; 리 오토, JD닷이 지난 주 대형주 상승률 10위 안에 포함되다 (9월 30일~10월 4일): 다른 주식들은 당신의 포트폴리오에 포함되어 있나요?</a></li>
</ul>
사진 출처: rafapress via Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

매일 거래일마다 벤징가 프로(Benzinga Pro)에서 수백 개의 헤드라인과 보도자료가 올라온다. 이는 트레이더들이 전체 시장 및 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100224&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">개별 종목</a>에 대한 최신 뉴스를 확인할 수 있는 소스이다.
2024년 9월에 Benzinga Pro에서 가장 많이 검색된 주식들을 살펴보겠다. 현재 가격과 연초 대비 성과는 9월 30일 기준이며 배당금은 포함되지 않았다.
1. 엔비디아 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
<ul>
<li>현재 가격: $121.44</li>
<li>52주 최고가/최저가: $39.23 ~ $140.76</li>
<li>연초 대비 수익률: +152.1%</li>
<li><a href="https://www.benzinga.com/top-stories/24/07/39579249/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-june-where-do-nvidia-gamestop-tesla-apple" target="_blank" rel="noopener" data-google-interstitial="false">6월</a>/<a href="https://www.benzinga.com/top-stories/24/08/40119459/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-july-2024-where-do-tesla-nvidia-apple-crow" target="_blank" rel="noopener" data-google-interstitial="false">7월</a>/<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40691773/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-august-2024-where-do-tesla-n" target="_blank" rel="noopener" data-google-interstitial="false">8월 </a>순위: 1위/2위/1위</li>
</ul>
2. SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)
<ul>
<li>현재 가격: $573.76</li>
<li>52주 최고가/최저가: $409.22 ~ $574.71</li>
<li>연초 대비 수익률: +21.4%</li>
<li>6월/7월/8월 순위: 3위/3위/2위</li>
</ul>
3. 테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
<ul>
<li>현재 가격: $261.63</li>
<li>52주 최고가/최저가: $138.80 ~ $271.00</li>
<li>연초 대비 수익률: +5.3%</li>
<li>6월/7월/8월 순위: 4위/1위/3위</li>
</ul>
4. 애플 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
<ul>
<li>현재 가격: $233.00</li>
<li>52주 최고가/최저가: $164.08 ~ $237.23</li>
<li>연초 대비 수익률: +25.5%</li>
<li>6월/7월/8월 순위: 5위/7위/6위</li>
</ul>
5. 휠러 리얼 에스테이트 인베스트 트러스트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>)
<ul>
<li>현재 가격: $8.09</li>
<li>52주 최고가/최저가: $2.90 ~ $1,126.80</li>
<li>연초 대비 수익률: -92.8%</li>
<li>6월/7월/8월 순위: 20위 미만</li>
</ul>
6. Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)
<ul>
<li>현재 가격: $488.07</li>
<li>52주 최고가/최저가: $342.35 ~ $503.52</li>
<li>연초 대비 수익률: +21.2%</li>
<li>6월/7월/8월 순위: 11위/11위/9위</li>
</ul>
7. 슈퍼 마이크로 컴퓨터 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)
<ul>
<li>현재 가격: $416.40</li>
<li>52주 최고가/최저가: $226.59 ~ $1,229.00</li>
<li>연초 대비 수익률: +45.9%</li>
<li>6월/7월/8월 순위: 10위/19위/4위</li>
</ul>
8. 갈메드 파마슈티컬스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLMD#NASDAQ">GLMD</a>)
<ul>
<li>현재 가격: $6.86</li>
<li>52주 최고가/최저가: $2.73 ~ $23.80</li>
<li>연초 대비 수익률: +29.9%</li>
<li>6월/7월/8월 순위: 20위 미만</li>
</ul>
9. 인텔 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)
<ul>
<li>현재 가격: $23.46</li>
<li>52주 최고가/최저가: $18.51 ~ $51.28</li>
<li>연초 대비 수익률: -50.9%</li>
<li>6월/7월/8월 순위: 20위 미만</li>
</ul>
10. 인튜이티브 머신스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>)
<ul>
<li>현재 가격: $8.05</li>
<li>52주 최고가/최저가: $2.09 ~ $13.25</li>
<li>연초 대비 수익률: +241.1%</li>
<li>6월/7월/8월 순위: 20위 미만/20위 미만/20위</li>
</ul>
순위 밖의 주식들: 다음 주식들이 2024년 9월에 Benzinga Pro에서 11위에서 20위까지 가장 많이 검색된 종목들다.
11. 서밋 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)
12. 팔란티어 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)
13. 마이크론 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>)
14. 테논 메디컬 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>)
15. CN 에너지 그룹 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>)
16. 취후오 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>)
17. 엔드라 라이프 사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>):
18. 어플라이드 디지털 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>)
19. 이뮤니어링 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>)
20. 트럼프 미디어 앤 테크놀로지 그룹 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>)
중요성 (Why It's Important): 엔비디아는 9월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식으로 다시 한번 선정되었다. 이 주식은 2월 이후로 매달 1위 또는 2위를 기록하고 있으며, 때때로 SPY 또는 테슬라와 교대로 1위에 올랐다.
SPDR S&amp;P 500 ETF Trust는 9월에 S&amp;P 500 추적 지수가 사상 최고치를 기록하면서 2위를 차지했다.
테슬라는 7월에 1위를 차지한 이후 두 주 연속 3위를 기록했다. 이 주식은 2024년 동안 매달 검색된 상위 4개의 주식 중 하나로 자리 잡았다.
9월의 큰 관심은 신규 진입 주식들과 순위에서 떨어진 주식들이었다.
신규 진입자로는 휠러 리얼 에스테이트, 갈메드, 인텔 및 인튜이티브가 포함되었다. 이 4개 주식 중에서 인튜이티브만이 지난 3개월 간 상위 20위에 랭크된 바 있다. 이 신규 진입자들은 모두 지난달에 주식을 크게 변동시킨 촉매제가 있었다.
11위에서 20위까지의 목록에서도 이전 달과는 모든 주식이 달랐으며 인튜이티브는 상위 10위로 올라갔고, 팔란티어는 7위에서 12위로 하락했으며 나머지 주식들은 모두 상위 20위에 신규로 진입했다.
상위 20위의 하위 주식들 중 일부는 주가가 $5 이하로 거래되는 저가 주식들이며, 이들 주식은 큰 변동성을 보이며 Benzinga 트레이더들의 관심이 증가했다.
상위 20위에 이름 인지도로 들어온 큰 회사는 트럼프 미디어 앤 테크놀로지 그룹으로, 전 대통령 도널드 트럼프가 공동 설립자이다. 이 주식은 2024년 선거 주기 동안 매우 변동성이 컸다.
상위 10위에서 떨어진 주식들은 루멘 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>), 어드밴스드 마이크로 디바이시스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), 지오백스 랩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) 및 앞서 언급한 팔란티어이다.
상위 20위에서 빠진 다른 큰 이름들은 8월에 13위였던 아마존닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)으로, 24위로 하락하여 리스트에 아슬아슬하게 들지 못했다.
메타 플랫폼스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)는 상위 20위에 자주 올라온 주식으로 8월에는 15위였으나 상위 20위에서 제외되었다.
전반적으로 9월에는 8월과 같은 상위 10개의 종목이 6개 있었고, 8월의 상위 20개 종목 중 8개가 포함되었다.
다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com/exclusives/24/07/39603613/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-first-half-2024-where-do-nvidia-tesla-pala">독점: 2024년 상반기 가장 많이 검색된 종목 TOP 10 – 엔비디아, 테슬라, 팔란티어, 게임스탑의 순위는?</a></li>
</ul>
이미지: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주가는 씨티그룹이 주식을 <a href="https://www.benzinga.com/quote/smmt/analyst-ratings" target="_blank" rel="noreferrer noopener">매수에서 중립으로 하향 조정</a>했으나 목표 주가를 19달러에서 23달러로 상향 조정한 후 14.37% 하락했다.
2. 메이크마이트립(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>)의 주식은 12.46% 급락했다.
3. 메드페이스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>)의 주식은 제프리스(Jefferies)가 주식을 매수에서 보유로 하향 조정하고 <a href="https://www.benzinga.com/quote/medp/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가를 415달러에서 345달러로 하향 조정</a>한 후 9.37% 하락했다.
4. 리제네론 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>)의 주식은 리링크 파트너스(Leerink Partners)가 주식을 아웃퍼폼에서 시장 수익률로 <a href="https://www.benzinga.com/quote/regn/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">하향 조정</a>하고 목표 주가를 1,175달러에서 1,077달러로 하향 조정한 후 8.94% 하락했다.
5. 글로벌 페이먼츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>)의 주가는 회사가 <a href="https://www.benzinga.com/pressreleases/24/09/b41024786/global-payments-shares-updated-strategy-and-medium-term-outlook-at-investor-conference" target="_blank" rel="noreferrer noopener">2025 회계연도 주당순이익(EPS) 성장률을 예상치 이하로 안내</a>한 후 여러 회사가 주식을 하향 조정하고 <a href="https://www.benzinga.com/quote/gpn/analyst-ratings" target="_blank" rel="noreferrer noopener">각각의 목표 주가를 하향 조정</a>한 후 8.74% 하락했다.
6. 어펌 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>)의 주식은 회사에 특별한 뉴스가 없었음에도 불구하고 8.39% 하락했다.
7. 슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)의 주식은 회사가 8월에 <a href="https://www.benzinga.com//node/41052423" target="_blank" rel="noreferrer noopener">힌덴버그 리서치</a>의 공매도 보고서에 따라 법무부의 조사를 받고 있다는 보도가 나온 후 8.21% 하락했다.
8. 테크닙FMC(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>)의 주식은 사우디아라비아가 원유 생산량을 증가시킬 수 있다는 보도에 따라 6.10% 하락했다.
9. 퍼스트 시티즌스 뱅크셰어스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>)의 주식은 웨드부시(Wedbush)의 애널리스트가 주식을 아웃퍼폼에서 중립으로 <a href="https://www.benzinga.com/quote/fcnca/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">하향 조정</a>하고 목표 주가를 2,450달러에서 2,150달러로 하향 조정한 후 6.09% 하락했다.
10. 서비스나우(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>)의 주식은 법무부의 카라소프트(Carahsoft) 조사 압박으로 인해 5.93% 하락했다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%A4%91%EA%B5%AD-%EC%A3%BC%EC%8B%9D-%EC%9A%B0%EC%84%B8-jd%EB%8B%B7%EC%BB%B4%EA%B3%BC-pdd%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC/" target="_blank" rel="noopener">중국 주식이 주도 &#8211; JD닷컴과 PDD가 지난주 대형주 상승 10위 안에 포함 (9월 23일 &#8211; 9월 27일)</a></li>
</ul>
사진 제공: 회사
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

AFRM

FCNCA

KNTK

MEDP

MMYT

REGN

리제네론과 슈퍼 마이크로는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (9월 23일-9월 27일)

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주식이 23.61% 하락했다. 이 회사는 새롭고 잠재적인 최초의 연구용 이중특이성 항체인 아이보네스시맙(ivonescimab)에 대한 데이터가 <a href="https://www.benzinga.com//node/40873837" target="_blank" rel="noreferrer noopener">2024년 ESMO 연례 회의</a>에서 발표되었다고 발표했다.
2. Joint Stock Company Kaspi.kz(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>)의 주식이 21.66% 급락했다. 이는 컬퍼 리서치(Culper Research)가 <a href="https://www.benzinga.com//node/40943334" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">이 회사에 대한 공매도 보고서를 발표</a>한 후 주가는 21.66% 하락했다.
3. 바이오마린 파마슈티컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>)의 주식이 16.74% 하락했다. 이는 경쟁사인 아센디스 파마(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>)의 <a href="https://www.benzinga.com//node/40885653" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">강력한 왜소증 치료제 데이터</a> 발표 이후 발생한 일이다.
4. 리비안 오토모티브(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>)의 주식이 <a href="https://www.benzinga.com//node/40961732" target="_blank" rel="noreferrer noopener">지난주</a> 13.26% 하락했다.
5. 페덱스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>)의 주식은 회사가 예상보다 나쁜 1분기 재무 결과를 보고하고 <a href="https://www.benzinga.com//node/40948046" target="_blank" rel="noreferrer noopener">2025 회계연도 가이던스를 하향 조정</a>한 후 11.08% 하락했다.
6. 바이오엔텍 SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>)의 주식이 9.01% 하락했다. 화이자(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)와 바이오엔텍은 유럽 연합에서 오미크론(omicron) KP.2 적응 <a href="https://www.benzinga.com//node/40956192" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">코로나19 백신</a>에 대해 긍정적인 CHMP 의견을 받았다.
7. 아서 J 갤러거(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>)의 주식이 7.17% 하락했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/ajg/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>한 후 발생한 일이다.
8. 츄이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>)의 주식이 6.97% 하락했다. 이는 회사가 주식 공모와 <a href="https://www.benzinga.com//node/40949015" target="_blank" rel="noreferrer noopener">동시 주식 매입</a>을 발표한 후 발생한 일이다.
9. 노보 노디스크 A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>)의 주식은 비만 환자를 대상으로 한 몬루나반트(monlunabant)의 <a href="https://www.benzinga.com//node/40961934" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">중간 단계 연구 결과가 헤드라인</a>을 장식한 후 6.93% 하락했다.
10. 머피 USA(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUSA#NYSE">MUSA</a>)의 주식이 6.90% 하락했다. 이는 JP 모건이 주식 등급을 중립에서 비중축소(Underweight)로 하향 조정했지만 <a href="https://www.benzinga.com/quote/musa/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가를 $415에서 $435로 상향 조정</a>한 후 발생한 일이다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%BD%98%EC%8A%A4%ED%85%94%EB%A0%88%EC%9D%B4%EC%85%98-%EB%B0%8F-%EC%B9%B4%EB%B0%94%EB%82%98%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC/" target="_blank" rel="noopener">콘스텔레이션 및 카바나는 지난주 최고 성과를 보여준 11개 대형주 중 일부 (9월 16일-9월 20일)</a></li>
</ul>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

ASND

BMRN

BNTX

CHWY

KSPI

MUSA

노보 노디스크, 츄이 및 페덱스는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (9월 15일-9월 21일)

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/40833208" target="_blank" rel="noreferrer noopener">$2억 3,500만</a>의 순수익을 올렸다고 발표한 후 98.32% 급등했다.
2. 바이오엔텍 SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>)의 주식은 GSK가 단순 포진 바이러스 백신 개발을 중단하자 모더나와 바이오엔텍와 같은 다른 경쟁자들에게 길을 열어주면서 지난주 31.77% 상승했다.
3. 앱러빈 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>)의 주식은 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/app/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가를 올린 후</a> 28.38% 상승했다.
4. 츄이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>)의 주식은 펫코 헬스 앤 웰니스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)의 <a href="https://www.benzinga.com//node/40822147" target="_blank" rel="noreferrer noopener">재무 결과 발표</a>에 동조하는 분위기 속에서 21.37% 상승했다.
5. 브로드컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)의 주식은 일부 반도체 주식의 <a href="https://www.benzinga.com//node/40852990" target="_blank" rel="noreferrer noopener">반등</a>으로 인해 20.81% 상승했다.
6. Arm 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>)의 주식은 레이먼드 제임스(Raymond James)가 주식을 아웃퍼폼(Outperform) 등급으로 분석을 시작하고 <a href="https://www.benzinga.com/quote/arm/analyst-ratings" target="_blank" rel="noreferrer noopener">$160의 목표 주가</a>를 발표한 후 20.50% 상승했다.
7. 마이크로스트레티지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)의 주식은 회사가 18,300개의 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)을 구매했다고 발표한 후 18.74% 상승했다.
8. 킨로스 골드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/40788842" target="_blank" rel="noreferrer noopener">그레이트 베어(</a><a href="https://www.benzinga.com//node/40788842" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">Great Bear</a><a href="https://www.benzinga.com//node/40788842" target="_blank" rel="noreferrer noopener">) 프로젝트</a>에 대한 초기 경제 평가를 완료했다고 발표한 후 17.14% 상승했다.
9. 워너 브라더스 디스커버리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>)의 주식은 최근 발표된 차터(Charter)와의 다년간 파트너십으로 인해 지난주 17.10% 상승했다. 이 파트너십은 선형 비디오와 스트리밍 서비스를 통합하여 비디오 번들의 유연성과 가치를 향상시킨다.
10. 버티브 홀딩스, LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>)의 주식은 17.02% 상승했다.
이미지 출처: Chewy
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

AVGO

EXAS

FSLR

MSTR

ROKU

WOOF

츄이, 브로드컴 및 ARM은 지난주 최고 성과를 보여준 10개 대형주 중 일부 (9월 8일-9월 14일)

다음은 지난주 큰 폭의 상승세를 보인 11개의 중형주 주식이다. 이 주식들은 여러분의 포트폴리오에 있나요?
<ol>
<li>퀀텀스케이프(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>)의 주가는 회사가 폭스바겐(Volkswagen)의 배터리 회사인 파워코(PowerCo)와 <a href="https://www.benzinga.com//node/39727990" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">전고체 배터리 산업화</a> 계약을 체결했다고 발표한 후 64.34% 급등했다.</li>
<li>랜티우스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>)의 주가는 전문 <a href="https://www.benzinga.com//node/39717130" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">진단 방사성 의약품</a>에 대한 지불 개선을 위한 CMS 제안 이후 55.93% 급등했다.</li>
<li>선런(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>)의 주가는 37.59% 상승했다. 최근 CPI 데이터에 따라 더 넓은 산업 분야의 기업 주가가 상승했기 때문이다.</li>
<li>키메라 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>)의 주가는 화농한선염과 아토피성 피부염에 대한 임상 2상을 확대해 <a href="https://www.benzinga.com//node/39675035" target="_blank" rel="noreferrer noopener">안전성 및 유효성</a>에 대한 중간 검토를 거쳐 중추적 연구로 보다 신속하게 진행하겠다는 의사를 밝힌 뒤 37.38% 상승했다.</li>
<li>아포지 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>)의 주식은 35.68% 급등했다.</li>
<li>조비 항공(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>)은 회사가 <a href="https://www.benzinga.com//node/39733461" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">물을 유일한 부산물</a>로 사용하여 523마일을 수소 전기 항공 택시 시연차로 성공적으로 비행했다고 발표한 후 주가는 29.10% 상승했다.</li>
<li>크리네틱스 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>)은 JP모건이 <a href="https://www.benzinga.com/quote/crnx/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">목표 주가를 47달러에서 54달러로</a> 상향 조정한 후 주가는 21.18% 상승했다.</li>
<li>다인 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>)은 JP모건이 주식에 대해 비중확대 등급을 유지하고 <a href="https://www.benzinga.com/quote/DYN/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">목표 주가를 39달러에서 43달러로</a> 높인 후 주가는 19.75% 상승했다.</li>
<li>서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주식은 지난주 17.24% 급등했다.</li>
<li>플러그 파워(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>)의 주가는 <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39728268/inflation-slows-more-expected-to-3-in-june-heightens-expectations-for-rate-cuts-t" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">최근 소비자물가지수(CPI) 발표</a> 이후 전기차 관련주가 상승하면서 16.51% 상승했다. 미국 에너지부는 또한 폐쇄되었거나 위험에 처한 11개의 자동차 시설을 전기 자동차와 공급망 제조를 위해 전환하는 데 17억 달러를 투자한다고 발표했다.</li>
<li>샤오펑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>)의 주식은 15.56% 상승했다. 6월 중국의 수출이 증가한 것을 계기로 중국 관련 주식이 상승했다.</li>
</ol>
기타 읽어볼 만한 기사:
<ul>
<li><a href="https://kr.benzinga.com/news/%eb%a6%ac%eb%b9%84%ec%95%88%ea%b3%bc-%eb%b0%94%ec%9d%b4%eb%91%90%eb%8a%94-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ea%b3%a0-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-11%ea%b0%9c%ec%9d%98-%eb%8c%80/" target="_blank" rel="noopener">리비안과 바이두는 지난주 최고 성과를 보인 11개의 대형주 주식 중 일부 (7월 7일-7월 13일)</a></li>
<li><a href="https://kr.benzinga.com/news/%eb%84%b7%ed%94%8c%eb%a6%ad%ec%8a%a4%ec%99%80-%eb%8d%b8%ed%83%80-%ed%95%ad%ea%b3%b5%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10/" target="_blank" rel="noopener">넷플릭스와 델타 항공은 지난주 최악의 성과를 보인 10대 대형주 중 일부 (7월 7일-7월 13일)</a></li>
</ul>
Photo Courtesy of QuantumScape
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Summit Therapeutics

뉴스

에 대한 최신 뉴스 Summit Therapeutics (NASDAQ:SMMT) 주식

월요일, 1월 27, 2025

일요일, 10월 06, 2024

수요일, 10월 02, 2024

월요일, 9월 30, 2024

월요일, 9월 23, 2024

일요일, 9월 15, 2024

월요일, 7월 15, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌